ivi.int

Public health protects and improves the health of an entire population, while personal health care treats individual patients. In Contra Costa County, both roles sit under one agency: Contra Costa Health provides direct medical care to Medi-Cal patients and also promotes public health for all county residents. That dual role is a useful way to see the difference — the same organization runs clinics and hospitals for individuals, and runs population-level programs like disease surveillance, food safety permitting, and vaccination outreach for everyone.

The core difference: a patient vs. a population

Personal health care is a transaction between a provider and a patient. You have symptoms, you get diagnosed, you get treated, you get billed. The unit of concern is you.

Public health flips the unit of concern to the whole community. Instead of asking "what does this person need?", it asks "what does this population need to stay healthy?" That shift changes almost everything:

The two overlap constantly. A tuberculosis outbreak, for example, needs both a public health team tracking who was exposed and personal medical care for each person infected.

What public health actually does day to day

Public health work is often invisible when it succeeds. Common functions include:

• Vaccination programs — making sure enough of the population is immunized to prevent outbreaks, not just vaccinating whoever walks in.
• Infectious disease monitoring — tracking reportable diseases so clusters get caught early.
• Food safety — inspecting restaurants and reviewing plans for new food facilities. Contra Costa Health, for instance, publishes food safety permit and plan review information for businesses.
• Environmental health — safe water, sewage, hazardous materials, and housing conditions.
• Health education and outreach — getting accurate information to communities, especially during emergencies.
• Mental health and substance use services — often delivered through county systems rather than private practices alone.

How an individual actually uses public health services

You rarely "sign up" for public health as a single service. You encounter it through specific channels:

1. Your county health department. Look up your county's health agency website for clinic locations, immunization schedules, and program eligibility. Contra Costa Health, for example, is the entry point for county residents.
2. Community clinics and county hospitals. These often serve people covered by Medi-Cal or without insurance, and they connect patients to public health programs.
3. Programs tied to coverage. Medi-Cal patients can receive direct care through county health systems, which is how personal care and public health funding often meet.
4. Public notices and data. Health departments publish outbreak alerts, inspection results, and guidance — useful even if you never become a patient.

How to participate or give feedback

Public health depends on residents reporting problems and showing up:

• Report foodborne illness, unsafe housing conditions, or other health hazards to your county health department.
• Attend community meetings or comment periods when the agency proposes programs or rules.
• Follow your local health department's announcements, especially during outbreaks or extreme weather.
• Use county services when eligible rather than avoiding care — utilization data shapes what programs get funded.

A practical way to decide where to go

If you have a personal symptom or condition, you need personal health care — a clinic, a doctor, a hospital. If your concern is about a shared risk (a restaurant making people sick, a disease spreading in your neighborhood, unsafe water), that is a public health matter, and your county health department is the right contact. In Contra Costa County, both paths start at the same agency, cchealth.org, which is why the distinction matters less in practice than it does in theory.

An international organization is an entity set up by governments, institutions, or private founders to work across national borders on issues that no single country can solve alone. The term covers several different structures, and the differences matter: an intergovernmental body derives authority from treaties between states, while a nonprofit or public-private organization operates more like a mission-driven institution with global reach. The International Vaccine Institute (IVI) is an example of the second type — an international organization for vaccine research, development, and delivery, headquartered in Seoul, Korea.

The main forms an international organization can take

The practical difference is who can compel what. An IGO can pass binding rules; a nonprofit international organization generally influences through research, programs, partnerships, and evidence rather than legal authority.

How IVI illustrates the model

IVI describes itself as uniquely present at every step of the vaccine value chain, which it breaks into four stages:

• Discover — early-stage vaccine research
• Develop — moving candidates toward usable products
• Deliver — getting vaccines to the populations that need them
• Build Capacity — training and strengthening systems in partner countries

Its stated purpose is to discover, develop, and deliver safe, effective, and affordable vaccines, with an emphasis on vaccine equity, impact, and sustainability. Two details show how this kind of organization operates across borders:

• Headquarters in Seoul, Korea, with work that is explicitly global rather than tied to one country's health system.
• A partner network — IVI's site lists global partners and notes agreements such as a Memorandum of Understanding with Karolinska Institutet to strengthen cooperation in vaccine research and education.

Its training work is another marker of the cross-border model: IVI marked 25 years of its International Vaccinology Course, with training connecting Seoul, Kigali, and Stockholm. That is a concrete example of an international organization acting as a connector — moving people, methods, and knowledge between regions rather than only producing a product.

How international organizations differ from governments, NGOs, and companies

• National governments set and enforce rules inside their own borders and fund public health through domestic budgets. An international organization has no such territorial authority.
• NGOs are usually founded and registered within one country, even when they work abroad. An international organization is structured from the outset around multiple countries or a global mission.
• Private companies answer to owners and customers, and price products for a market. IVI's framing around affordable vaccines and equity signals a different accountability logic — one oriented to public health impact and donors rather than profit.

These lines blur in practice. Many global health efforts are public-private, with governments, companies, foundations, and institutes each contributing funding, research, or distribution.

How to judge whether an international organization is credible

Use the same checks you would apply to any cross-border institution:

1. Identify the legal form and founders. Is it treaty-based, nonprofit, or a partnership? Who established it, and under what agreement?
2. Check governance and funding. Look for a published list of governing bodies, member states, and major donors. Funding sources shape priorities.
3. Look for named partners. IVI's site lists global partners and specific institutional agreements — named partners are easier to verify than general claims of collaboration.
4. Find primary output, not just mission language. Annual reports, peer-reviewed publications, and program results are stronger evidence than slogans. IVI, for instance, points readers to its annual report and to program updates such as the conclusion of ECHO-M, which advanced sustainable cholera prevention and control in Mozambique.
5. Match scope to the problem. An organization focused on vaccine R&D and delivery will not be the right source for, say, trade rules or refugee law.

Where to start if you want to follow IVI's work

• Read the annual report for a year-in-review of programs and finances.
• Browse the news and announcements section for partnerships, awards, and course milestones.
• Check the blog for field-level observations, such as surveillance work or the close of a cholera prevention program.
• Use the mailing list if you want updates delivered rather than checking back.

The general takeaway: "international organization" is a category, not a single structure. Before you rely on one — as a researcher, donor, partner, or just an informed reader — establish its legal form, who funds and governs it, and what it has actually produced. IVI's own framing, from its Seoul headquarters to its four-stage vaccine value chain and its named global partners, gives you a working template for running those checks on any similar body.

The International Vaccine Institute (IVI) is an international organization for vaccine research and development and delivery, headquartered in Seoul, Korea. It describes itself as uniquely present at every step of the vaccine value chain—discover, develop, deliver, and build capacity—with the stated aim of advancing vaccine equity, impact, and sustainability globally. If you want to understand who IVI is, what it actually works on, and how organizations or individuals can engage with it, the sections below cover each of those questions.

What IVI is

IVI is not a manufacturer or a regulator. Its own framing places it as an international organization focused on vaccine R&D and delivery, working across the full chain rather than at a single stage. Its mission statement emphasizes discovering, developing, and delivering safe, effective, and affordable vaccines.

Two practical implications follow from that positioning:

• It works on vaccines that may not attract purely commercial development. The affordability and equity language in its mission points toward diseases where market incentives alone are weak.
• It spans research through delivery. Many research institutes stop at publication or proof of concept; IVI's stated scope extends to delivery and capacity building, which is where field implementation and training come in.

What IVI does: the four-stage value chain

IVI organizes its work around four stages, and this is the clearest way to describe its activities:

The "build capacity" stage is easy to overlook but shows up concretely in IVI's programs. IVI marked 25 years of its International Vaccinology Course, described as global training connecting Seoul, Kigali, and Stockholm—an example of capacity building operating as a multi-site training program rather than a one-off workshop.

Disease areas and focus

IVI's public materials reference work on several infectious diseases, including:

• Cholera — the blog notes the conclusion of ECHO-M, described as advancing sustainable cholera prevention and control in Mozambique.
• Strep A — a blog post describes a traditional gift capturing the impact of Strep A surveillance.
• Typhoid — referenced in IVI's focus areas alongside cholera and Strep A.

These examples are useful because they show the pattern: surveillance, prevention and control programs, and sustained country-level work, not just laboratory research. If your interest is in a specific disease, the disease area is a better entry point than the organization's general structure.

Partnerships and collaboration

IVI works through formal partnerships. Two examples from its announcements:

• IVI and Karolinska Institutet signed a Memorandum of Understanding to strengthen existing cooperation in vaccine research and education.
• The IVI-KVS Young Scientist Award recognized Prof. Soo-Jin Jung of Sogang University as its second recipient.

For an institution considering collaboration, the pattern to note is that IVI's partnerships tend to combine research and education or training components, and they are formalized through instruments like MoUs and named awards. A university, research group, or health ministry exploring a relationship would reasonably expect the same shape: a defined joint activity in research, training, or both.

How to follow or support IVI

IVI offers a few direct ways to engage, based on its site:

• Subscribe to the mailing list — the site has a subscription field for news updates (with a Korean-language prompt, 새소식 구독하기, alongside it).
• Read the annual report — IVI points to its 2025 Annual Report for a fuller picture of activities and results.
• Donate — the site includes a donation call framed as helping make vaccines a reality for all.
• Follow news, announcements, and the blog — these carry partnership news, program completions, and field stories.

One caution: the site's donation and subscription options do not by themselves indicate that IVI's services, training, or materials are free or open to everyone. If you are considering applying to a course, proposing a partnership, or requesting data, check the specific program page or contact IVI directly rather than assuming terms from the homepage.

Quick orientation

• What it is: an international vaccine R&D and delivery organization based in Seoul.
• What it does: discover, develop, deliver, and build capacity across the vaccine value chain.
• What it works on: infectious disease prevention, with named examples including cholera, typhoid, and Strep A.
• How to engage: partnerships and MoUs, training programs like the International Vaccinology Course, mailing list subscription, annual report, and donations.

Vaccines work by teaching your immune system to recognize and fight a specific pathogen before you encounter it in real life. When you receive a vaccine, your body mounts a practice response—producing antibodies and memory cells—so that if the actual virus or bacteria enters your system later, your defenses are already prepared. This protection applies to both individual health and community-wide disease prevention.

How Vaccines Train Your Immune System

Your immune system identifies threats through markers called antigens—unique proteins or sugars on the surface of viruses and bacteria. A vaccine introduces these antigens in a safe form, without causing the disease itself. Your immune system responds by:

1. Recognizing the antigen as foreign.
2. Producing antibodies tailored to that specific pathogen.
3. Creating memory cells that remain in your body long-term.

If you later encounter the real pathogen, those memory cells trigger a faster, stronger response—often stopping the infection before you feel sick.

Common Types of Vaccines

Different vaccine platforms deliver antigens in different ways. The table below outlines the main types:

Each type has different storage, dosing, and eligibility considerations. Your healthcare provider can advise which is appropriate for your situation.

What to Expect After Vaccination

Mild reactions are common and typically resolve within a few days. They are a sign your immune system is responding. Common reactions include:

• Soreness, redness, or swelling at the injection site
• Fatigue
• Low-grade fever
• Headache or muscle aches

To manage these: rest, stay hydrated, and use a cool compress on the injection site. Over-the-counter pain relievers may help, but check with a provider first. Severe reactions—such as difficulty breathing, swelling of the face or throat, or a rapid heartbeat—require immediate medical attention.

How Vaccines Contribute to Community Protection

When a high proportion of a population is vaccinated, a pathogen has fewer opportunities to spread. This indirect protection—sometimes called herd immunity or community immunity—helps shield people who cannot be vaccinated, such as infants, those with certain medical conditions, or people with weakened immune systems. The threshold needed varies by disease; measles, for example, requires a very high vaccination rate to prevent outbreaks.

Where to Find Reliable Vaccine Information

Contra Costa Health (cchealth.org) provides public health information for county residents, including vaccination guidance. Community clinics, primary care providers, and local public health departments are also reliable sources. When evaluating any vaccine information, look for:

• Clear attribution to public health authorities or medical institutions
• Updates reflecting current recommendations
• Guidance specific to your age, health status, and location

If you have questions about which vaccines are right for you or your family, speaking with a healthcare provider is the most direct way to get personalized answers.

Global health is the study and practice of improving health for populations worldwide, with a focus on health equity between and within countries. It differs from personal medical care, which treats individuals, and from public health, which typically operates within one country's borders. Global health work is relevant to you if you follow international disease outbreaks, fund or volunteer for health organizations, work in medicine or research, or simply want to understand how vaccines and treatments reach people in low-resource settings.

The core idea: populations, borders, and equity

Global health addresses health problems that cross national boundaries or that no single country can solve alone. Three features define it:

• Population-level focus. It measures outcomes across groups—infection rates, mortality, vaccine coverage—rather than the health of one patient.
• Cross-border collaboration. Governments, international organizations, research institutes, and funders coordinate because diseases and their solutions do not stop at borders.
• Equity as a goal. A central concern is reducing avoidable differences in health between rich and poor countries, and between groups within a country.

A useful contrast: if a doctor treats a child with cholera, that is personal medical care. If a national agency tracks cholera cases and organizes a vaccination campaign, that is public health. If a research institute develops an affordable cholera vaccine and helps introduce it in multiple countries, that is global health.

Who does the work, and what each part does

Global health is not one organization. It is a system of actors with different roles.

The International Vaccine Institute (IVI) is an example of a research institute in this system. According to its website, IVI "discovers, develops, and delivers safe, effective, and affordable vaccines" and describes itself as "uniquely present at every step of the vaccine value chain"—Discover, Develop, Deliver, Build Capacity. It is an international organization for vaccine R&D and delivery headquartered in Seoul, Korea. This illustrates a common pattern in global health: a specialized institution handles one part of the problem (vaccines) while partners handle regulation, funding, and delivery.

What global health work actually involves

Most global health activity falls into a few recurring categories:

• Research and development. Creating vaccines, drugs, and diagnostics for diseases that disproportionately affect low- and middle-income countries—where commercial incentives alone may be insufficient.
• Delivery and access. Getting proven products to the people who need them, which involves supply chains, cold storage, pricing, and health worker training.
• Surveillance and disease control. Tracking outbreaks and monitoring disease burden so responses can be targeted. IVI's blog, for instance, describes work such as Strep A surveillance and a cholera prevention and control project in Mozambique.
• Capacity building. Training scientists, clinicians, and program managers so countries can run their own research and programs. IVI notes that it marked 25 years of its International Vaccinology Course, with training connecting Seoul, Kigali, and Stockholm.
• Emergency response. Mobilizing rapidly during outbreaks, often coordinated across many organizations.

How it differs from public health and personal care

These three fields overlap but answer different questions:

• Personal medical care: What does this individual patient need? Delivered by clinicians; success measured per patient.
• Public health: What does this country's population need? Run by national and local agencies; success measured in national statistics.
• Global health: What do populations across countries need, and how do we reduce inequities between them? Requires international coordination; success measured in cross-country comparisons and equity gains.

In practice, the boundaries blur. A national immunization program (public health) may rely on a vaccine developed by an international institute (global health) and delivered by local clinics (personal care).

How to follow or get involved

If you want to engage with global health rather than just understand it, practical entry points include:

1. Read primary sources. International organizations publish annual reports, outbreak updates, and guidance documents. IVI, for example, offers a 2025 Annual Report and a mailing list for updates.
2. Follow a specific problem. Pick one disease or issue—cholera, immunization coverage, vaccine equity—and track it through organization blogs and news announcements rather than trying to absorb the whole field at once.
3. Look for training. Global health courses and fellowships exist at many levels; IVI's International Vaccinology Course is one example of a training program that spans multiple countries.
4. Support access initiatives. Organizations working on vaccine equity accept donations and partnerships; IVI's site includes a "Donate" option framed as helping "make vaccines a reality for all."
5. Check the actor's role before trusting a claim. Because global health involves many organizations, it helps to know whether a source sets standards, funds work, does research, or delivers services—each has different authority and different limits.

The field is best understood not as a single institution but as a division of labor: researchers create tools, funders pay for them, agencies set rules, and national programs put them to use. Knowing which part you are looking at makes global health news much easier to interpret.